Biotech. MicroSan mf DNA Fmarker ENDOSCOPE REPROCESSING VERIFICATION SYSTEM ITALIAN INVESTMENT SHOWCASE TURIN /// APRIL 2018

Transcription

1 Biotech MicroSan mf DNA Fmarker ENDOSCOPE REPROCESSING VERIFICATION SYSTEM ITALIAN INVESTMENT SHOWCASE TURIN /// APRIL 2018 GeckoBiotech Srl Via Andrea Doria Roma

2 PROBLEM: HOW CLEAN ARE ENDOSCOPES IN THE HOSPITAL? SOLUTION: REPROCESSING VERIFICATION METHOD BY RT-PCR KIT Nosocomial infections accounts for 7% in developed and 10% in developing countries (1). Contaminated endoscopes are the medical devices frequently associated with outbreaks of health care-associated infections (2). Quality assurance in hygiene and infection control is an important tool in preventing nosocomial infections, whether endoscopy procedures are performed in hospitals, in private clinics, or doctor s offices (3). (1) Nosocomial infections: Epidemiology, prevention, control and surveillance (2) Transmission of Infection by Flexible Gastrointestinal Endoscopy and Bronchoscopy (3) ESGE-ESGENA technical specification for process validation and routine testing of endoscope reprocessing in washer-disinfectors according to EN ISO 15883, parts 1, 4, and ISO/TS To reduce the risk of infections different guidelines have been published (ESGE and ESGENA, CDC and others) but we need a method of checking the respect of guidelines (4). New technologies allow the development of faster monitoring kits to check the effectiveness clean of endoscopes after reprocessing (4) ESGE-ESGENA technical specification for process validation and routine testing of endoscope reprocessing in washer-disinfectors according to EN ISO 15883, parts 1, 4, and ISO/TS

3 PRODUCT WHY MICROSAN IS THE BEST SOLUTION ON THE MARKET MicroSan mf DNA Fmarker Is an innovative kit based on RT-PCR Method to determine the absence of indicators of contamination after reprocessing procedure on flexible endoscope. Core of Method The method is based on the search for traces of biological indicators associated with the microflora of the different biological districts of the human body. Compliance Our kits are compliance with ISO and different guidelines by endoscopy associations. HIGH SPECIFICITY HIGH SENSIBILITY EASY TO USE VALIDATED METHOD RESULTS IN 180 MINUTES COMPLIANCE WITH EN ISO 15833

4 METHOD COMPARISON WHY MICROSAN IS THE BEST SOLUTION ON THE MARKET METHOD COMPARISON: CLEANING VERIFICATION METHODS EASY OF USE SPEED QUANTITATIVE SPECIFICITY ECONOMICITY RT-PCR MICROBIOLOGY ATP TESTING BLACKLIGHT VISUAL INSP

5 MARKET SIZE INFECTION CONTROL EQUIPMENT AND DEVICE FOR HEALT-CARE Global infection control market by type, (USD Billion) 3,9 B$ 2,6 B$ GLOBAL MARKET SIZE (2017) 2.585,1 M$ CAGR 4,8% GLOBAL MARKET SIZE (2025) 3.852,5 M$ CAGR 5,1% ATTRACTIVE INDEX 2,14 EQUIPMENT SERVICES CONSUMABLE Global infection control market share, by end-use, 2016 (%) END-USER (Main Clients) 12,5% HOSPITAL Hospitals Clinical Laboratories Research department Medical Device Companies Pharmaceutical companies Others 15% 41,6% 14,2% 16,7% MEDICAL DEVICE COMPANIES CLINICAL LAB. /RESEARCH CENTERS PHARMACEUTICAL COMPANIES OTHERS DISINFECTION EQUIPMENT AND DEVICE IS 49,6% OF GLOBAL MARKET

6 COMPETITORS MAIN COMPETITORS AND HIS PRODUCT PRODUCT COMPARISON: CLEANING VERIFICATION PRODUCT Clean Trace Micro Snap Test Swab MicroSan mfdna PRODUCER 3M HYGIENA RUHOF GECKOBIOTECH OTHERS METHODS ATP ATP ATP RT-PCR EASE OF USE QUANTITATIVE SPECIFICITY SPEED TRAINING TOOL SOFTWARE ECONOMICITY Ready to use cultures Microbiology testing

7 Business Model HOW WE WANT TO EARN, MAIN STAKEHOLDER AND CUSTOMERS DIRECT CHANNEL HOSPITAL DISINFECTION SERVICE COMPANY RESERCH AND DEVELOPMENT COMPANY COMMERCIAL PARTNER MEDICAL CLINICS DOCTOR S OFFICES MEDICAL DEVICE FACTORY

8 TEAM WHO WE ARE, OUR TEAM PARTNERS OUR PARTNER PIER FRANCESCO RAPISARDA Chairman and Co-founder of GeckoBiotech Linkedin: Pier Francesco Rapisarda CRISTIANO REFI Sales Manager and Co-founder of GeckoBiotech Linkedin: Cristiano Refi Ing. DANIELE VERDEMARE Product Manager and member of GeckoBiotech Linkedin: Daniele Verdemare Prof. VINCENZO ROMANO SPICA Scientific Director of GeckoBiotech Linkedin: Vincenzo Romano Spica Dott.ssa FEDERICA VALERIANI Reserch and Development director of GeckoBiotech Linkedin: GIANLUCA GIANFRANCESCHI laboratory technician of GeckoBiotech Linkedin:

9 COLLABORATION OUR PARTNERS AND COLLABORATOS

10 TIMELINE WHAT WE HAVE DONE ROAD MAP WHAT WE WILL DO PATENT ACQUISITION PRODUCTION VALIDATION METHOD GO TO MARKET START UP CONSTITUITION RESERCH AND DEVELOPMENT

11 INVESTMENT HOW MUCH MONEY WHAT MONEY IS USED FOR PROJECT DURATION 24 MONTH 1M 35% LABORATORY & PRODUCTION 45% RESEARCH & DEVELOPMENT 20% SOFTWARE DEVELOPMENT 350 K 450 K 200 K

12 CONTACT US Mail Phone Web Facebook geckobiotech Linkedin GeckoBiotech Srl FOLLOW US: